0 Table of Contents |
1 Accueil |
2 Analyse automatique |
3 Téléchargements et usages |
4 Méthode |
5 Résultats |
6 Discussion |
7 Glossaire |
8 Artifacts Summary |
8.1 CareSite OMOP Table |
8.2 Concept OMOP Table |
8.3 Condition Era OMOP Table |
8.4 Condition Occurrence OMOP Table |
8.5 Cost OMOP Table |
8.6 Death OMOP Table |
8.7 Device Exposure OMOP Table |
8.8 Dose Era OMOP Table |
8.9 Drug Era OMOP Table |
8.10 Drug Occurrence OMOP Table |
8.11 Episode Event OMOP Table |
8.12 Episode OMOP Table |
8.13 Fact Relationship OMOP Table |
8.14 Location OMOP Table |
8.15 LogicalBundle |
8.16 Measurement OMOP Table |
8.17 Note NLP OMOP Table |
8.18 Note OMOP Table |
8.19 Observation OMOP Table |
8.20 Observation Period OMOP Table |
8.21 Payer Plan Period OMOP Table |
8.22 Person OMOP Table |
8.23 Procedure Occurrence OMOP Table |
8.24 Provider OMOP Table |
8.25 Specimen OMOP Table |
8.26 Visit Detail OMOP Table |
8.27 Visit Occurrence OMOP Table |
8.28 Profil de Claim pour le champ MCO du PMSI |
8.29 Profil de Claim pour le PMSI |
8.30 Résultat de laboratoire |
8.31 Activité physique |
8.32 Blood Pressure |
8.33 Body Height |
8.34 Body Weight |
8.35 Consommation d'alcool |
8.36 Consommation d'autres drogues |
8.37 Consommation de tabac |
8.38 Fonction rénale |
8.39 French branded name Medication |
8.40 French compound Medication |
8.41 French non proprietary name Medication |
8.42 French Ucd Part Medication |
8.43 Patient |
8.44 Prescription de médicaments |
8.45 Prise de médicaments |
8.46 RSS du PMSI MCO |
8.47 Temps de céphaline activée |
8.48 Urémie |
8.49 Address |
8.50 Range with UCUM quantity units |
8.51 Ratio with UCUM quantity units |
8.52 SimpleQuantity with UCUM quantity unit |
8.53 Actes CCAM pour le PMSI |
8.54 Exercice Status Type |
8.55 French Medicinal product Dose form |
8.56 French Medicinal Product only |
8.57 French Route of Administration |
8.58 Liste des analyses biologiques socle des EDS |
8.59 Liste des analyses correspondant à l'estimation du DFG - socle des EDS |
8.60 Liste des diagnostiques CIM-10 acceptable en DA pour les PMSI MCO et HAD |
8.61 Liste des diagnostiques CIM-10 acceptable en DP pour les PMSI MCO et HAD |
8.62 Liste des diagnostiques CIM-10 acceptable en DR pour les PMSI MCO et HAD |
8.63 Liste des diagnostiques CIM-10 pour le PMSI |
8.64 Liste des status pour l'Observation de consommation de tabac |
8.65 Liste des unités possibles pour une estimation du débit de filtration glomérulaire - socle des EDS |
8.66 Smoking status comprehensive |
8.67 Smoking Status Pack Years SCT |
8.68 Smoking Status Type |
8.69 Smoking Status Type from LOINC |
8.70 ValueSet des type fr des claims |
8.71 Categorie d'information pour les supporting information |
8.72 CCAM |
8.73 CIM 10 PMSI |
8.74 mode PMSI |
8.75 type de diagnostic du PMSI MCO |
8.76 type PMSI |
8.77 Mapping Patient resource to Death OMOP Domain |
8.78 Mapping Patient resource to Location OMOP Domain |
8.79 Mapping Observation laboratory resources to Measurement OMOP Domain |
8.80 FHIR EDS Patient to Tables CDM OMOP |
8.81 Mapping Patient resource to Person OMOP Domain |
8.82 Mapping simple Observation laboratory resources to Measurement OMOP Domain |
8.83 HL7 Gender to OHDSI Gender |
8.84 LabAnalyses |
8.85 LabComparator |
8.86 LabUnit |
8.87 alcohol-use-status-example-1 |
8.88 assurance-maladie |
8.89 blood-pressure-example-1 |
8.90 body-height-example-1 |
8.91 body-weight-example-1 |
8.92 claim-example-1 |
8.93 coverage-example-1 |
8.94 exercise-status-example-1 |
8.95 exercise-status-example-2 |
8.96 laboratory-fonction-renale-example-1 |
8.97 laboratory-tca-example-1 |
8.98 laboratory-uremie-example-1 |
8.99 organization-psl |
8.100 patient-example-1 |
8.101 practitioner-role-example-1 |
8.102 smoke-use-status-example-1 |
8.103 substance-use-status-example-1 |